ARTICLES ABOUT WOCKHARDT BY DATE - PAGE 2

MUMBAI: The S&P BSE Sensex surged as much as 241 points in trade on Tuesday, led by gains in HDFC, ITC , Axis Bank and ICICI Bank. Investors are optimistic of reforms and business-friendly policies in the Budget 2015. Tracking the momentum, the 50-share Nifty index also surged past its crucial resistance level of 8600, supported by gains in banks, metal, FMCG and realty stocks. According to analysts, the macro environment has also improved and corporates are likely to report better earnings in coming quarters.

In a chat with ET Now, Mitesh Thacker of miteshthacker.com, shares his views on Wockhardt Ltd ET Now: What is your view on Wockhardt Ltd? Mitesh Thacker: Wockhardt Ltd is a 'BUY' call with a target of Rs 1160 and a stop loss of Rs 1070

In a chat with ET Now, Ashwani Gujral of ashwanigujral.com, shares his views on Wockhardt Ltd ET Now: What is your view on Wockhardt Ltd? Ashwani Gujral: Wockhardt Ltd is a 'BUY' call with a target of Rs 1075 and a stop loss of Rs 1010.

In a chat with ET Now,Ashwani Gujral, Fund Manager, Ashwanigujral.com, shares his views on Wockhardt . ET Now: What is your view on Wockhardt? Ashwani Gujral: Wockhardt is a 'SELL' call with a target of Rs 990 and a stop loss of Rs 1,070.

In a chat with ET Now,Sandeep Wagle, Founder & CEO, Power My Wealth , shares his views on Wockhardt ET Now: What is your view on Wockhardt? Sandeep Wagle: Wockhardt is a 'BUY' call with a target of Rs 1160 and a stop loss of Rs 1,065

In a chat with ET Now , Ashwani Gujral of ashwanigujral.com , shares his views on Wockhardt Ltd ET Now: What is your view on Wockhardt Ltd? Ashwani Gujral: Wockhardt Ltd is a 'BUY' call with a target of Rs 1120 and a stop loss of Rs 1060

In a chat with ET Now, Sandeep Wagle , Founder & CEO, Power My Wealth, shares his views on Wockhardt Ltd ET Now: What is your view on Wockhardt Ltd? Sandeep Wagle: Wockhardt Ltd is a 'BUY' call with a target of Rs 1115 and a stop loss of Rs 1045.

In a chat with ET Now, Mitesh Thacker of miteshthacker.com, shares his views on Wockhardt Ltd ET Now: What is your view on Wockhardt Ltd? Mitesh Thacker: Wockhardt Ltd is a 'BUY' call with a target of Rs 1125 and a stop loss of Rs 1034.

NEW DELHI: Drug firms Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain lots of drugs in the US, according to the US Food and Drug Administration (USFDA). As per the information available on the USFDA website, Wockhardt USA , the US-based arm of the company, is recalling 11,18,400 Metoprolol Succinate extended-release tablets, a hypertension drug, for 'failed dissolution specifications'. The tablets have been manufactured by Mumbai-based Wockhardt and distributed by Wockhardt USA. The nationwide recall has been initiated by the company on April 17 this year and initiated under Class-III which FDA defined as "a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences".

In a chat with ET Now, Deven Choksey, MD, KR Choksey Securities, shares his views on the mid sized pharma companies. Edited Excerpts: ET Now: What about midsized pharmas? They have had a fabulous last three months, be it a Wockhardt , Strides or Pfizer . Natco Pharma is in a league of its own too. Is there a player that you like here? Do you like the business model? Do you like a business model of any of the players? Deven Choksey: Yes certainly. Many companies and particularly one of the company which we are having under our recommendation.